NL7314765A - - Google Patents

Info

Publication number: NL7314765A
Authority: NL; Netherlands

Application number

NL7314765A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-10-31

Filing date

1973-10-26

Publication date

1974-05-02

1973-10-26 Application filed filed Critical

1974-05-02 Publication of NL7314765A publication Critical patent/NL7314765A/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NL7314765A 1972-10-31 1973-10-26 NL7314765A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE2253317		1972-10-31
DE2253318		1972-10-31

Publications (1)

Publication Number	Publication Date
NL7314765A true NL7314765A (fr)	1974-05-02

Family

ID=25764031

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL7314765A NL7314765A (fr)	1972-10-31	1973-10-26

Country Status (8)

Country	Link
US (1)	US3883648A (fr)
JP (1)	JPS5046821A (fr)
AT (1)	AT341099B (fr)
CA (1)	CA1004142A (fr)
DE (1)	DE2355743A1 (fr)
FR (1)	FR2204425B1 (fr)
GB (1)	GB1445995A (fr)
NL (1)	NL7314765A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE5852T1 (de) *	1978-11-20	1984-02-15	American Home Products Corporation	Therapeutische zusammensetzungen mit gesteigerter bioverfuegbarkeit und verfahren zu deren herstellung.
US4344934A (en) *	1978-11-20	1982-08-17	American Home Products Corporation	Therapeutic compositions with enhanced bioavailability
FR2470599A1 (fr) *	1979-12-07	1981-06-12	Panoz Donald	Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB2118040A (en) *	1982-02-15	1983-10-26	Hoechst Uk Ltd	Oral anti-diabetic preparation
DE3320582A1 (de) *	1983-06-08	1984-12-13	Dr. Karl Thomae Gmbh, 7950 Biberach	Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
DE3320583A1 (de) *	1983-06-08	1984-12-13	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
DE3325986C2 (de) *	1983-07-19	1985-05-23	Klinge Pharma GmbH, 8000 München	Schnell resorbierbare Zubereitung schwer löslicher Wirkstoffe
DE3326167A1 (de) *	1983-07-20	1985-02-21	Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim	Feste arzneiformen, die als wirkstoff n-4-(2-(5-chlor-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'-cyclohexylharnstoff enthalten und verfahren zu ihrer herstellung
US4783334A (en) *	1986-01-21	1988-11-08	Chugai Seiyaku Kabushiki Kaisha	Stable solid preparation of thiol ester derivative
DE3833439A1 (de) *	1988-10-01	1991-09-12	Hoechst Ag	Verfahren zur mikronisierung von glibenclamid
EP1882414A1 (fr) *	2006-07-29	2008-01-30	Bayer CropScience AG	Granules fondus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2875130A (en) *	1956-11-20	1959-02-24	Smith Kline French Lab	Method of preparing sustained release particles and the product of the method
US3146167A (en) *	1961-10-05	1964-08-25	Smith Kline French Lab	Method of preparing sustained release pellets and products thereof
US3361632A (en) *	1964-05-08	1968-01-02	Hoechst Ag	Medicinal preparations having a protracted activity and method of making them
DE1467938C3 (de) *	1964-05-22	1973-12-20	F. Hoffmann-La Roche & Co Ag, Basel (Schweiz)	Wasserdispergierbares Arzneipräparat für Tiere
FR1487897A (fr) *	1965-07-27	1967-07-07	Hoechst Ag	Benzène-sulfonyl-urées et leur préparation
US3374146A (en) *	1966-04-18	1968-03-19	American Cyanamid Co	Sustained release encapsulation
NL6808619A (fr) *	1968-06-19	1969-12-23
NL7112288A (fr) *	1970-09-16	1972-03-20
DE2055930A1 (de) *	1970-11-13	1972-05-18	Boehringer Mannheim Gmbh, 6800 Mannheim	Verbesserte orale Applikationsform von Raubasin

1973
- 1973-10-26 NL NL7314765A patent/NL7314765A/xx unknown
- 1973-10-29 US US410311A patent/US3883648A/en not_active Expired - Lifetime
- 1973-10-30 AT AT916573A patent/AT341099B/de not_active IP Right Cessation
- 1973-10-30 CA CA184,767A patent/CA1004142A/en not_active Expired
- 1973-10-31 GB GB5065373A patent/GB1445995A/en not_active Expired
- 1973-10-31 JP JP48121878A patent/JPS5046821A/ja active Pending
- 1973-10-31 FR FR7338928A patent/FR2204425B1/fr not_active Expired
- 1973-11-08 DE DE19732355743 patent/DE2355743A1/de active Pending

Also Published As

Publication number	Publication date
DE2355743A1 (de)	1975-05-22
GB1445995A (en)	1976-08-11
CA1004142A (en)	1977-01-25
JPS5046821A (fr)	1975-04-25
ATA916573A (de)	1977-05-15
US3883648A (en)	1975-05-13
FR2204425A1 (fr)	1974-05-24
AT341099B (de)	1978-01-25
FR2204425B1 (fr)	1977-04-22

Publication	Publication Date	Title
FR2204425B1 (fr)	1977-04-22
JPS5342217B2 (fr)	1978-11-09
JPS5125912B2 (fr)	1976-08-03
JPS537774Y2 (fr)	1978-02-28
JPS4944800A (fr)	1974-04-27
JPS5122812Y2 (fr)	1976-06-12
JPS4913217U (fr)	1974-02-04
JPS4986149U (fr)	1974-07-25
JPS4912858U (fr)	1974-02-02
JPS49111960U (fr)	1974-09-25
JPS526355Y2 (fr)	1977-02-09
JPS5528167B2 (fr)	1980-07-25
JPS4970897A (fr)	1974-07-09
JPS4973833U (fr)	1974-06-26
CS163974B1 (fr)	1975-11-07
CH567697A5 (fr)	1975-10-15
NL7311171A (fr)	1974-02-19
CH563915A5 (fr)	1975-07-15
CH563768A5 (fr)	1975-07-15
CH563641A5 (fr)	1975-06-30
CH563639A5 (fr)	1975-06-30
CH563053A5 (fr)	1975-06-13
CH564978A5 (fr)	1975-08-15
CH562942A5 (fr)	1975-06-13
CH565686A5 (fr)	1975-08-29